What is the recommended treatment for uncomplicated cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Uncomplicated Cellulitis

For uncomplicated cellulitis, the recommended first-line treatment is a 5-day course of antibiotics targeting Streptococcus and methicillin-sensitive Staphylococcus aureus (MSSA), such as cephalexin 500 mg four times daily or amoxicillin-clavulanate 875/125 mg twice daily. 1

Antibiotic Selection

First-line options (oral therapy):

  • Cephalexin 500 mg four times daily for 5 days
  • Amoxicillin-clavulanate 875/125 mg twice daily for 5 days
  • Cloxacillin 500 mg four times daily for 5 days
  • Dicloxacillin (dosage based on weight) for 5 days

For penicillin-allergic patients:

  • Clindamycin 300-450 mg orally three times daily for 5 days
  • Doxycycline 100 mg twice daily for 5 days (avoid in children under 8 years)

For severe cases requiring parenteral therapy:

  • Nafcillin
  • Cefazolin
  • Clindamycin or vancomycin (for patients with life-threatening penicillin allergies) 2

Duration of Treatment

A 5-day course of antibiotics is as effective as a 10-day course for uncomplicated cellulitis 2, 3. In a randomized, double-blind, placebo-controlled trial, 5 days of therapy with levofloxacin was shown to be equally effective as 10 days of therapy, with a 98% success rate in both groups 3.

MRSA Considerations

For uncomplicated, non-purulent cellulitis, MRSA coverage is generally not necessary 4. However, MRSA coverage should be considered in specific high-risk populations:

  • Athletes
  • Children
  • Men who have sex with men
  • Prisoners
  • Military recruits
  • Residents of long-term care facilities
  • Those with prior MRSA exposure
  • Intravenous drug users 5

If MRSA coverage is needed, options include:

  • Trimethoprim-sulfamethoxazole 1-2 DS tablets twice daily
  • Doxycycline 100 mg twice daily
  • Clindamycin 300-450 mg orally three times daily
  • Linezolid 600 mg twice daily 1

Adjunctive Measures

  1. Elevation of the affected area - This important and often neglected aspect of treatment promotes gravity drainage of edema and inflammatory substances 2, 1
  2. Keep the area clean and dry - Daily cleansing with chlorhexidine or povidone-iodine solution may be considered 1
  3. Address underlying conditions - Treat predisposing factors such as tinea pedis, venous eczema, or trauma 2

Management of Recurrent Cellulitis

For patients with 3-4 episodes of cellulitis per year despite addressing predisposing factors, consider prophylactic antibiotics:

  • Oral penicillin V 1 g twice daily
  • Erythromycin 250 mg twice daily
  • Intramuscular benzathine penicillin 1.2 million units every 2-4 weeks 2, 1

Common Pitfalls to Avoid

  1. Misdiagnosis - Cellulitis can be confused with conditions like venous stasis dermatitis, contact dermatitis, eczema, and lymphedema 4
  2. Failure to address predisposing factors - Treating underlying conditions is essential for preventing recurrence 1
  3. Inadequate treatment duration - While 5 days is typically sufficient, therapy should be extended if clinical response is inadequate 1
  4. Overuse of broad-spectrum antibiotics - Vancomycin and newer agents should be reserved for severe infections or confirmed MRSA 1
  5. Failure to drain purulent collections - Antibiotics alone are often insufficient for abscesses 1

Response to Treatment

If there is no improvement within 2-3 days of starting appropriate antibiotics, consider:

  1. Resistant organisms
  2. Secondary conditions that mimic cellulitis
  3. Underlying complicating conditions (immunosuppression, chronic liver disease, chronic kidney disease) 5

In cases of slow response, systemic corticosteroids may be considered as an adjunct in selected adult patients without diabetes or pregnancy to hasten resolution 2.

References

Guideline

Wound Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.